Benign Paroxysmal Positional Vertigo (BPPV) in Nursing Homes: Treatment Efficacy and Impact on Balance, Gait and Falls
Launched by HASSELT UNIVERSITY · Aug 18, 2021
Trial Information
Current as of May 11, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Institutionalized for at least 3 months
- • Willing to participate
- • Able to understand simple instructions
- • Able to stand independently for 10 seconds (with the use of a walking aid)
- Exclusion Criteria:
- • Diagnosis of progressive neurological conditions resulting in a fast deterioration (i.e. amyotrophic lateral sclerosis or residents with palliative care)
- • Participation in a rehabilitation program at the current time for a pathology of less than 6 months
- • Contra-indication for vestibular testing such as heart failure or fear
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leopoldsburg, , Belgium
Patients applied
Trial Officials
Joke Spildooren, prof. dr.
Principal Investigator
Hasselt University
Laura Casters, drs.
Study Chair
Hasselt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials